Showing 1-10 of about 107 articles.
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 9, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today the effectiveness of its six-to-one reverse stock split (the "Reverse Stock Split") of Nabi...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the three-month period ended September 30, 2012. The...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that Nabi's Board of Directors declared a special cash dividend in the aggregate of approximately...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that its board of directors (the "Board") has established a ratio of one share-for-every six...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today the results of the reconvened special meeting of Nabi stockholders held on October 22, 2012 (the...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 19, 2012 (GLOBE NEWSWIRE) -- Nabi today announced that, if the proposed business combination transaction between Nabi Biopharmaceuticals (Nasdaq:NABI) and Biota Holdings Limited...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 17, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that the phase II study of NicVAX® (Nicotine Conjugate Immunotherapeutic) in combination...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 16, 2012 (GLOBE NEWSWIRE) -- Nabi today announced that Nabi's Board of Directors has set October 26, 2012 as the record date with respect to the cash dividend to be paid in...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Oct. 16, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nadsaq:NABI) ("Nabi") today announced that the two major independent proxy advisory firms, Institutional Shareholder Services...
Nabi Biopharmaceuticals
ROCKVILLE, Md., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that its Special Meeting of Stockholders scheduled for September 24, 2012 has been adjourned to...
Showing 1-10 of about 107 articles.
